Improvements in Daily Activity and Exercise in School Children: the ActChild Study
Launched by UNIVERSITY OF AARHUS · Jan 22, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
The ActChild Study is a clinical trial designed to explore how a special exercise program can help improve the health and well-being of children aged 5 to 8 years old. The main focus is to see if a program led by the local community can increase how active children are, help them sleep better, improve their eating habits, and enhance their overall quality of life. In this study, some children will participate in fun exercise sessions 1 to 2 times a week for a year, while others will not take part in the program and will be observed to compare the results.
To join the study, children must be in the first or second grade and live in Aarhus Municipality. There are no specific health problems that would prevent them from participating. Throughout the study, families will complete questionnaires and children will wear special devices that track their activity levels for a week, both at the beginning and again after one, three, and five years. This research aims to understand the long-term benefits of exercise on children's health and habits.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Schoolchildren, 0.-1. Grade, 5-8 years of age,
- • Resident in Aarhus Municipality
- Exclusion Criteria:
- • - None
About University Of Aarhus
The University of Aarhus, a prestigious research institution located in Denmark, is dedicated to advancing medical science through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the university fosters an environment that encourages cutting-edge research and the development of novel therapeutic interventions. Committed to ethical standards and patient safety, the University of Aarhus aims to contribute to the global body of medical knowledge while enhancing healthcare outcomes through rigorous scientific inquiry and evidence-based practices.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Aarhus, , Denmark
Patients applied
Trial Officials
Jens M Bruun, Professor
Principal Investigator
Aarhus University and Steno Diabetes Center Aarhus
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported